Linda Henry

459 total papers · 37.1k total citations
278 papers, 24.6k citations indexed

About

Linda Henry is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Linda Henry has authored 278 papers receiving a total of 24.6k indexed citations (citations by other indexed papers that have themselves been cited), including 195 papers in Epidemiology, 153 papers in Hepatology and 46 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Linda Henry's work include Liver Disease Diagnosis and Treatment (183 papers), Hepatitis C virus research (87 papers) and Liver Disease and Transplantation (84 papers). Linda Henry is often cited by papers focused on Liver Disease Diagnosis and Treatment (183 papers), Hepatitis C virus research (87 papers) and Liver Disease and Transplantation (84 papers). Linda Henry collaborates with scholars based in United States, China and United Kingdom. Linda Henry's co-authors include Zobair M. Younossi, Aaron B. Koenig, Yousef Fazel, Dinan Abdelatif, Quentin M. Anstee, Maria Stepanova, Elisabetta Bugianesi, M. Marietti, Timothy Hardy and Jacob George and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Linda Henry

269 papers receiving 24.2k citations

Hit Papers

Global epidemiology of no... 2015 2026 2018 2022 2015 2017 2023 2016 2015 2.5k 5.0k 7.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
    2015 7.7k citations Zobair M. Younossi, Aaron B. Koenig et al. Hepatology profile →
  2. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
    2017 3.8k citations Zobair M. Younossi, Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology profile →
  3. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
    2023 1.5k citations Zobair M. Younossi, Pegah Golabi et al. Hepatology profile →
  4. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
    2016 906 citations Zobair M. Younossi, Deirdre B Blissett et al. Hepatology profile →
  5. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
    2015 589 citations Zobair M. Younossi, Munkhzul Otgonsuren et al. Hepatology profile →
  6. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
    2020 578 citations Qing Ye, Biyao Zou et al. ˜The œLancet. Gastroenterology & hepatology profile →
  7. Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes
    2020 433 citations Jie Li, Daniel Q. Huang et al. Journal of Medical Virology profile →
  8. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World
    2015 407 citations Mehmet Sayıner, Aaron B. Koenig et al. Clinics in Liver Disease profile →
  9. Epidemiology of chronic liver diseases in the USA in the past three decades
    2019 384 citations Zobair M. Younossi, Maria Stepanova et al. Gut profile →
  10. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States
    2020 365 citations Zobair M. Younossi, Maria Stepanova et al. Clinical Gastroenterology and Hepatology profile →
  11. The Global Burden of Liver Disease
    2023 207 citations Zobair M. Younossi, Grace Lai–Hung Wong et al. Clinical Gastroenterology and Hepatology profile →
  12. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
    2022 164 citations Michael H. Le, Yee Hui Yeo et al. Clinical and Molecular Hepatology profile →
  13. Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons
    2023 154 citations Michael H. Le, Yuankai Wu et al. Journal of Hepatology profile →
  14. Global burden of NAFLD and chronic liver disease among adolescents and young adults
    2021 145 citations James M. Paik, Khaled W. Kabbara et al. Hepatology profile →
  15. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease
    2024 144 citations Zobair M. Younossi, James M. Paik et al. Journal of Hepatology profile →
  16. Lifestyle interventions in nonalcoholic fatty liver disease
    2023 139 citations Zobair M. Younossi, Shira Zelber‐Sagi et al. Nature Reviews Gastroenterology & Hepatology profile →
  17. Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world
    2022 117 citations Linda Henry, James M. Paik et al. Alimentary Pharmacology & Therapeutics profile →
  18. Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease?
    2022 115 citations Zobair M. Younossi, James M. Paik et al. Hepatology profile →
  19. The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019
    2023 91 citations James M. Paik, Linda Henry et al. Hepatology Communications profile →
  20. The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction–associated steatotic liver disease and alcohol-associated liver disease
    2023 68 citations Zobair M. Younossi, Maria Stepanova et al. Hepatology Communications profile →
  21. Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action
    2024 35 citations Zobair M. Younossi, Linda Henry Diabetes Spectrum profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Linda Henry 20.0k 10.1k 7.4k 3.0k 2.9k 278 24.6k
Leon A. Adams 18.8k 0.9× 9.1k 0.9× 7.8k 1.1× 2.9k 0.9× 3.0k 1.0× 202 22.8k
Quentin M. Anstee 19.4k 1.0× 8.9k 0.9× 7.9k 1.1× 4.0k 1.3× 3.1k 1.1× 253 23.6k
Stephen A. Harrison 25.5k 1.3× 11.3k 1.1× 12.0k 1.6× 5.4k 1.8× 4.6k 1.6× 404 31.8k
Kris V. Kowdley 19.9k 1.0× 14.4k 1.4× 5.1k 0.7× 3.2k 1.0× 5.6k 1.9× 450 29.2k
Christopher D. Byrne 16.8k 0.8× 5.2k 0.5× 10.4k 1.4× 4.1k 1.4× 4.1k 1.4× 501 26.7k
Elisabetta Bugianesi 27.5k 1.4× 10.5k 1.0× 12.8k 1.7× 5.4k 1.8× 4.4k 1.5× 295 32.9k
Jeanne M. Clark 12.9k 0.6× 4.9k 0.5× 7.7k 1.0× 2.4k 0.8× 4.3k 1.5× 233 21.6k
Giulio Marchesini 24.6k 1.2× 10.8k 1.1× 12.4k 1.7× 3.9k 1.3× 5.4k 1.9× 469 35.6k
Arthur J. McCullough 28.0k 1.4× 12.0k 1.2× 12.0k 1.6× 5.5k 1.8× 6.0k 2.1× 292 35.2k
Valério Nobili 11.5k 0.6× 3.7k 0.4× 6.0k 0.8× 3.0k 1.0× 2.8k 1.0× 288 15.9k

Countries citing papers authored by Linda Henry

Since Specialization
Citations

This map shows the geographic impact of Linda Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Henry more than expected).

Fields of papers citing papers by Linda Henry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Henry. The network helps show where Linda Henry may publish in the future.

Co-authorship network of co-authors of Linda Henry

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Henry. A scholar is included among the top collaborators of Linda Henry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Henry. Linda Henry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Simmons Breakdown of academic impact, for papers by Serge Muyldermans Breakdown of academic impact, for papers by Anthony J. Downs Breakdown of academic impact, for papers by Xianluo Hu Breakdown of academic impact, for papers by Charles R. Marmar Breakdown of academic impact, for papers by Mitchell P. Fink Breakdown of academic impact, for papers by Robert K. Wayne Breakdown of academic impact, for papers by John M. Zachara
Rankless by CCL
2026